Hospital Clinic Provincial

Barcelona 08036

1 studies enrolling now · 2 studies all time

What they study most

Advanced Hepatocellular Carcinoma (HCC), HER2-positive Breast Cancer

Studies at this site

• RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive — Recruiting now
• A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC — Stopped early